Dr. Timothy Brand, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Tulane University School of Medicine (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 549
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Tulane University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
FL license ME142597
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sacred Heart Hospital Pensacola, FL
- Baptist Hospital Pensacola, FL
- Gulf Breeze Hospital Gulf Breeze, FL
- Jay Hospital Jay, FL
Medical groups
- Baptist Medical Group LLC (256 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 549
- Services billed
- 1,414
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 416 | 302 |
| Established patient office or other outpatient visit, 20-29 minutes | 131 | 127 |
| New patient office or other outpatient visit, 45-59 minutes | 120 | 120 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 117 | 31 |
| Diagnostic exam of bladder and urethra using an endoscope | 112 | 103 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 32 | 32 |
| Biopsy of prostate gland | 30 | 30 |
| Insertion of stent in ureter using an endoscope | 25 | 20 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 22 | 22 |
| Limited ultrasound scan of abdomen | 19 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Pensacola, FL | 248 |
| Finasteride Other prescribers in Pensacola, FL | 138 |
| Myrbetriq (mirabegron) Other prescribers in Pensacola, FL | 90 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Pensacola, FL | 67 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Pensacola, FL | 36 |
| Oxybutynin Chloride Other prescribers in Pensacola, FL | 34 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Pensacola, FL | 34 |
| Gemtesa (vibegron) Other prescribers in Pensacola, FL | 32 |
| Testosterone Cypionate Other prescribers in Pensacola, FL | 27 |
| Tolterodine Tartrate Er (tolterodine tartrate) Other prescribers in Pensacola, FL | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 36 payments worth $928 in total to this clinician.
| Teleflex LLC | $152 |
|---|---|
| Janssen Biotech, Inc. | $138 |
| Intuitive Surgical, Inc. | $87.50 |
| Boston Scientific Corporation | $82.97 |
| Sumitomo Pharma America, Inc. | $79.14 |
| Medtronic, Inc. | $68.25 |
| Urogen Pharma, Inc. | $51.43 |
| Pfizer Inc. | $46.03 |
| Food and Beverage | $909 |
|---|---|
| Education | $19.31 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation Apr 24, 2025 | Education PLUVICTO · Oncology · in-kind | $19.31 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.